Cargando…

Neutralizing antibodies against the SARS-CoV-2 Omicron variant following two CoronaVac vaccinations and a Pfizer/BioNTech mRNA vaccine booster

Detalles Bibliográficos
Autores principales:	da Silva, Almir Ribeiro, Villas-Boas, Lucy Santos, de Paula, Anderson Vicente, Tozetto-Mendoza, Tania Regina, Honorato, Layla, Witkin, Steven S., Mendes-Correa, Maria Cassia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Instituto de Medicina Tropical de São Paulo 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208660/ https://www.ncbi.nlm.nih.gov/pubmed/35730869 http://dx.doi.org/10.1590/S1678-9946202264043

Ejemplares similares

Generation of neutralizing antibodies against Omicron, Gamma and Delta SARS-CoV-2 variants following CoronaVac vaccination
por: da Silva, Almir Ribeiro, et al.
Publicado: (2022)

Cutaneous reactions after CoronaVac and BioNTech vaccines
por: Öner, Ümran, et al.
Publicado: (2022)

DETECÇÃO DE ANTICORPOS NEUTRALIZANTES CONTRA AS VARIANTES DELTA, GAMA E OMICRON APÓS IMUNIZAÇÃO POR CORONAVAC E BOOSTER COM PFIZER
por: da Silva, Almir Ribeiro, et al.
Publicado: (2022)

The Effects of CoronaVac (Sinovac) and BNT162b2 (BioNTech/Pfizer) Vaccination on Oncologic (18)F-FDG PET/CT Studies
por: Şan, Hüseyin, et al.
Publicado: (2022)

Immunogenicity, efficacy, and safety of CoronaVac and Pfizer/BioNTech mRNA vaccines in patients with psoriasis receiving systemic therapies: A prospective cohort study
por: Ergun, Tulin, et al.
Publicado: (2023)

Self-reported reactogenicity of CoronaVac (Sinovac) compared with Comirnaty (Pfizer-BioNTech): A prospective cohort study with intensive monitoring
por: Lai, Francisco Tsz Tsun, et al.
Publicado: (2022)

Humoral immunity against SARS-CoV-2 evoked by heterologous vaccination groups using the CoronaVac (Sinovac) and BNT162b2 (Pfizer/BioNTech) vaccines in Chile
por: Díaz-Dinamarca, Diego A., et al.
Publicado: (2023)

Heterologous booster vaccination with CoronaVac following prime vaccination with mRNA vaccine
por: Goh, Yun Shan, et al.
Publicado: (2022)

Heterologous booster vaccination with CoronaVac following prime vaccination with mRNA vaccine
Publicado: (2023)

Neutralizing antibodies induced by homologous and heterologous boosters in CoronaVac vaccines in Chile
por: Acevedo, Johanna, et al.
Publicado: (2023)

The COVID-19 Humoral Immunological Status Induced by CoronaVac and AstraZeneca Vaccines Significantly Benefits from a Booster Shot with the Pfizer Vaccine
por: Farias, Jessica Pires, et al.
Publicado: (2022)

Effectiveness of the BNT162b2 and the CoronaVac vaccines and boosters in healthcare workers
por: Çulpan, Hazal Cansu, et al.
Publicado: (2023)

Myocarditis with Pfizer-BioNTech's COVID-19 vaccine in Israel
Publicado: (2021)

Thrombocytopenia with Pfizer-BioNTech or Moderna COVID-19 vaccines
Publicado: (2021)

Pfizer-BioNTech COVID-19 vaccine safe in children
Publicado: (2022)

Tachycardia following Pfizer-BioNTech COVID-19 vaccine
por: Martins-Filho, Paulo Ricardo
Publicado: (2023)

Pfizer-BioNTech COVID-19 vaccine safe with clozapine
Publicado: (2022)

Tachycardia following Pfizer-BioNTech COVID-19 vaccine
por: Martins-Filho, Paulo Ricardo
Publicado: (2023)

Miller Fisher syndrome after Pfizer BioNTech vaccine booster responsive to intravenous Ig treatment
por: Chen, Baibing, et al.
Publicado: (2022)

Minimal change disease following vaccination with CoronaVac
por: Dirim, Ahmet Burak, et al.
Publicado: (2021)

ANCA-associated vasculitis following the CoronaVac vaccination
por: Ma, Yaohui, et al.
Publicado: (2022)

Covid-19-vaccine-Pfizer-BioNTech: Vaccine failure: case report
Publicado: (2021)

Pfizer-BioNTech COVID-19 vaccine-related risk of anaphylaxis
Publicado: (2021)

Managing allergic reactions to Pfizer-BioNTech COVID-19 vaccine
Publicado: (2021)

COVID-19-Vaccine-Pfizer-BioNTech: Thyroiditis: case report
Publicado: (2021)

Pfizer-BioNtech's COVID-19 vaccine approved for younger adolescents
Publicado: (2021)

Pfizer-BioNTech COVID-19 vaccine in patients with severe allergies
Publicado: (2021)

Anaphylaxis after Pfizer-BioNTech COVID-19 vaccine in Japan
Publicado: (2021)

COVID-19-Vaccine-Pfizer-BioNTech: Anaphylaxis: case report
Publicado: (2022)

COVID-19-Vaccine-Pfizer-BioNTech: Myocarditis: case report
Publicado: (2022)

No evidence of TTS risk with Pfizer/BioNTech's COVID-19 vaccine
Publicado: (2021)

Pfizer-BioNTech COVID-19 vaccine safe in older Koreans
Publicado: (2021)

Adverse reactions with Pfizer/BioNTech's COVID-19 vaccine in Ecuador
Publicado: (2021)

Pityriasis Rosea Following Pfizer-BioNTech Vaccination in an Adolescent Girl
por: Bin Rubaian, Nouf F, et al.
Publicado: (2022)

Comment on “Tachycardia following Pfizer-BioNTech COVID-19 vaccine”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Comment on “Tachycardia following Pfizer-BioNTech COVID-19 vaccine”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Prolonged angioedema after Pfizer-BioNTech COVID-19 vaccine
por: Muhamad Fauzi, Siti Mardhiah
Publicado: (2023)

Immunogenicity of Mix-and-Match CoronaVac/BNT162b2 Regimen versus Homologous CoronaVac/CoronaVac Vaccination: A Single-Blinded, Randomized, Parallel Group Superiority Trial
por: Samoud, Samar, et al.
Publicado: (2023)

Humoral immunogenicity and reactogenicity of CoronaVac or ZF2001 booster after two doses of inactivated vaccine
por: Cao, Yunlong, et al.
Publicado: (2021)

Leukocytoclastic vasculitis after the third dose of CoronaVac vaccination
por: Oskay, T., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6t8c1t194mcg1bigrjsbbaohp8